RESUMO
INTRODUCTION: This study aimed to determine whether the COVID-19 pandemic had an impact on essential primary healthcare services at public primary healthcare facilities. METHODS: The number of weekly consultations for antenatal care (ANC), outpatient (OPD), immunisations (EPI), family planning (FP) and HIV services, between January 2018 and December 2020, were collected from 25 facilities in Masaka district, Uganda, 21 in Goma, and 29 in Kambia district, Sierra Leone. Negative binomial regression models accounting for clustering and season were used to analyse changes in activity levels between 2018, 2019 and 2020. RESULTS: In Goma, we found no change in OPD, EPI or ANC consultations, FP was 17% lower in March-July 2020 compared to 2019, but this recovered by December 2020. New diagnoses of HIV were 34% lower throughout 2020 compared to 2019. In Sierra Leone, compared to the same periods in 2019, facilities had 18-29% fewer OPD consultations throughout 2020, and 27% fewer DTP3 doses in March-July 2020. There was no evidence of differences in other services. In Uganda there were 20-35% fewer under-5 OPD consultations, 21-66% fewer MCV1 doses, and 48-51% fewer new diagnoses of HIV throughout 2020, compared to 2019. There was no difference in the number of HPV doses delivered. CONCLUSIONS: The level of disruption varied across the different settings and qualitatively appeared to correlate with the strength of lockdown measures and reported attitudes towards the risk posed by COVID-19. Mitigation strategies such as health communications campaigns and outreach services may be important to limit the impact of lockdowns on primary healthcare services.
Assuntos
COVID-19 , Infecções por HIV , Humanos , Feminino , Gravidez , COVID-19/epidemiologia , Serra Leoa/epidemiologia , Uganda/epidemiologia , República Democrática do Congo , Pandemias , Controle de Doenças Transmissíveis , Cuidado Pré-Natal , Atenção Primária à SaúdeRESUMO
BACKGROUND: The multi-dose regimen is a known barrier to successful human papillomavirus (HPV) vaccination. Emerging evidence suggests that one vaccine dose could protect against HPV. While there are clear advantages to a single dose schedule, beliefs about vaccine dosage in low and middle income countries (LMICs) are poorly understood. We investigated acceptability of dose-reduction among girls, and parents/guardians of girls, randomised to receive one, two or three doses in an HPV vaccine dose-reduction and immunobridging study (DoRIS trial) in Tanzania. METHODS: Semi-structured interviews with girls (n = 19), and parents/guardians of girls (n = 18), enrolled in the study and completing their vaccine course. RESULTS: Most participants said they entrusted decisions about the number of HPV vaccine doses to experts. Random allocation to the different dose groups did not feature highly in the decision to participate in the trial. Given a hypothetical choice, girls generally said they would prefer fewer doses in order to avoid the pain of injections. Parental views were mixed, with most wanting whichever dose was most efficacious. Nonetheless, a few parents equated a higher number of doses with greater protection. CONCLUSION: Vaccine trials and programmes will need to employ careful messaging to explain that one dose offers sufficient protection against HPV should emerging evidence from ongoing dose-reduction clinical trials support this.
Assuntos
Infecções por Papillomavirus , Vacinas contra Papillomavirus , Redução da Medicação , Feminino , Humanos , Infecções por Papillomavirus/prevenção & controle , Tanzânia , VacinaçãoRESUMO
During the last 12â¯years, over 80 countries have introduced national HPV vaccination programs. The majority of these countries are high or upper-middle income countries. The barriers to HPV vaccine introduction remain greatest in those countries with the highest burden of cervical cancer and the most need for vaccination. Innovation and global leadership is required to increase and sustain introductions in low income and lower-middle income countries.
Assuntos
Países em Desenvolvimento/economia , Vacinação em Massa/economia , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/administração & dosagem , Neoplasias do Colo do Útero/prevenção & controle , Adolescente , Adulto , Criança , Custos e Análise de Custo , Feminino , Saúde Global/economia , Humanos , Renda , Infecções por Papillomavirus/epidemiologia , Vacinas contra Papillomavirus/uso terapêutico , Neoplasias do Colo do Útero/epidemiologia , Neoplasias do Colo do Útero/terapiaRESUMO
Demonstration projects or pilots of new public health interventions aim to build learning and capacity to inform country-wide implementation. Authors examined the value of HPV vaccination demonstration projects and initial national programmes in low-income and lower-middle-income countries, including potential drawbacks and how value for national scale-up might be increased. Data from a systematic review and key informant interviews, analyzed thematically, included 55 demonstration projects and 8 national programmes implemented between 2007-2015 (89 years' experience). Initial demonstration projects quickly provided consistent lessons. Value would increase if projects were designed to inform sustainable national scale-up. Well-designed projects can test multiple delivery strategies, implementation for challenging areas and populations, and integration with national systems. Introduction of vaccines or other health interventions, particularly those involving new target groups or delivery strategies, needs flexible funding approaches to address specific questions of scalability and sustainability, including learning lessons through phased national expansion.
Assuntos
Países em Desenvolvimento , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/administração & dosagem , Vacinas contra Papillomavirus/imunologia , Projetos Piloto , HumanosRESUMO
BACKGROUND: Completion of multiple dose vaccine schedules is crucial to ensure a protective immune response, and maximise vaccine cost-effectiveness. While barriers and facilitators to vaccine uptake have recently been reviewed, there is no comprehensive review of factors influencing subsequent adherence or completion, which is key to achieving vaccine effectiveness. This study identifies and summarises the literature on factors affecting completion of multi-dose vaccine schedules by adolescents. METHODS: Ten online databases and four websites were searched (February 2014). Studies with analysis of factors predicting completion of multi-dose vaccines were included. Study participants within 9-19 years of age were included in the review. The defined outcome was completion of the vaccine series within 1 year among those who received the first dose. RESULTS: Overall, 6159 abstracts were screened, and 502 full texts were reviewed. Sixty one studies were eligible for this review. All except two were set in high-income countries. Included studies evaluated human papillomavirus vaccine, hepatitis A, hepatitis B, and varicella vaccines. Reported vaccine completion rates, among those who initiated vaccination, ranged from 27% to over 90%. Minority racial or ethnic groups and inadequate health insurance coverage were risk factors for low completion, irrespective of initiation rates. Parental healthcare seeking behaviour was positively associated with completion. Vaccine delivery in schools was associated with higher completion than delivery in the community or health facilities. Gender, prior healthcare use and socio-economic status rarely remained significant risks or protective factors in multivariate analysis. CONCLUSIONS: Almost all studies investigating factors affecting completion have been carried out in developed countries and investigate a limited range of variables. Increased understanding of barriers to completion in adolescents will be invaluable to future new vaccine introductions and the further development of an adolescent health platform. PROSPERO reg# CRD42014006765.
Assuntos
Esquemas de Imunização , Vacinação/estatística & dados numéricos , Adolescente , Vacina contra Varicela/administração & dosagem , Criança , Etnicidade/estatística & dados numéricos , Feminino , Vacinas contra Hepatite A/administração & dosagem , Vacinas contra Hepatite B/administração & dosagem , Humanos , Cobertura do Seguro/estatística & dados numéricos , Seguro Saúde , Masculino , Vacinas contra Papillomavirus/administração & dosagem , Aceitação pelo Paciente de Cuidados de Saúde , Fatores de Risco , Adulto JovemRESUMO
OBJECTIVES: A study found screening (with rapid plasma reagin (RPR)) pregnant women for maternal syphilis was cost-effective in Mwanza, Tanzania. Recently, four rapid point-of-care (POC) syphilis tests were evaluated in Mwanza, and found to have reasonable sensitivity/specificity. This analysis estimates the relative cost-effectiveness of using these POC tests in the Mwanza syphilis screening intervention. METHODS: Empirical cost and epidemiological data were used to model the potential benefit of using POC tests instead of RPR. Reductions in costs relating to training, supplies, and equipment were estimated, and any changes in impact due to test sensitivity were included. Additional modelling explored how the results vary with prevalence of past infection, misclassified RPR results, and if not all women return for treatment. RESULTS: The cost-effectiveness of using POC tests is mainly dependent on their cost and sensitivity for high titre active syphilis (HTAS). Savings due to reductions in training and equipment are small. Current POC tests may save more disability-adjusted life years (DALYs) than the RPR test in Mwanza, but the test cost needs to be <0.63 US dollars to be as cost-effective as RPR. However, the cost-effectiveness of the RPR test worsens by 15% if its HTAS sensitivity had been 75% instead of 86%, and by 25-65% if 20-40% of women had not returned for treatment. In such settings, POC tests could improve cost-effectiveness. Lastly, the cost-effectiveness of POC tests is affected little by the prevalence of syphilis, false RPR-positives, and past infections. DISCUSSION: Although the price of most POC tests needs to be reduced to make them as cost-effective as RPR, their simplicity and limited requirements for electricity/equipment suggest their use could improve the coverage of antenatal syphilis screening in developing countries.
Assuntos
Programas de Rastreamento/economia , Sistemas Automatizados de Assistência Junto ao Leito/economia , Complicações Infecciosas na Gravidez/diagnóstico , Diagnóstico Pré-Natal/economia , Sorodiagnóstico da Sífilis/economia , Sífilis/diagnóstico , Análise Custo-Benefício , Feminino , Humanos , Programas de Rastreamento/normas , Gravidez , Complicações Infecciosas na Gravidez/economia , Diagnóstico Pré-Natal/normas , Sensibilidade e Especificidade , Sífilis/economia , Sorodiagnóstico da Sífilis/normas , TanzâniaRESUMO
The seroprevalence of cystic echinococcosis in north-western Mongolia was determined in a cross-sectional study of 334 semi-nomadic pastoralists in their summer grazing areas. Overall, 5.2% of the subjects were found to be strongly seropositive for antibodies to Echinococcus granulosus antigen B by ELISA. Only 10% of the adult subjects (aged > or = 15 years) had heard of the disease and only 5% recognized hydatid cysts in their livestock (in contrast to the neighbouring province in China, where 76% had seen and recognized cysts in the organs of slaughtered animals). The close association between Mongolian pastoralists, their dogs and livestock is likely to encourage ready transmission of the parasite in a region where home slaughter is practised and offal for various scavengers, including domestic dogs. Further information is needed to determine the prevalence of infection in other intermediate hosts and in dogs and the clinical importance of the disease in this remote region.
Assuntos
Equinococose/epidemiologia , Adolescente , Adulto , Idoso , Anticorpos Anti-Helmínticos/sangue , Criança , Estudos Transversais , Feminino , Humanos , Imunoglobulina G/sangue , Masculino , Pessoa de Meia-Idade , Mongólia/epidemiologia , Projetos Piloto , PrevalênciaRESUMO
Despite a hostile environment unsuited to parasite transmission, Turkana district in northwestern Kenya has the highest incidence of hydatid disease in the world. The prevalence of the disease varies ten-fold, being higher in the north than the south of the district. This study examined whether differences in man:dog contact and specific activities of dogs enhanced the transmission of Echinococcus granulosus eggs to man. A total of 24,541 observation-minutes were completed, studying 31 dogs from 20 manyattas in six locations throughout Turkana district, and in one location in neighbouring Pokot. Correlations were found between the time a dog spent in a manyatta and whether dogs were allowed to clean children, scavenge from cooking utensils and defecate within the home area. The amount of time a dog spent in a manyatta depended upon the availability of water, food and shade. The study also revealed that it is difficult to change the Turkana's behaviour and attitudes towards their dogs, despite continuous education. Therefore, in an area where home slaughter is practised, dosing of dogs with a suitable taeniacide will for many years to come remain an important component in the hydatid control programme being carried out in Turkana.